Research area
Multiple Sclerosis (MS) medication trials
Your first step is finding out whether an MS study may be a fit for you, and CNS Medication Trials can help with that. These studies examine investigational medications and rehabilitation approaches for relapsing and progressive forms of multiple sclerosis.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Multiple sclerosis medication studies in numbers
- multiple sclerosis medication studies recruiting in the U.S.
- 53
- states with a study site
- 38
- studies that accept healthy volunteers
- 11
Source: ClinicalTrials.gov. Data processed .
Find multiple sclerosis medication studies by state
These states have the most studies recruiting right now.
California
19 studies recruiting.
Massachusetts
16 studies recruiting.
Maryland
14 studies recruiting.
Florida
12 studies recruiting.
New York
12 studies recruiting.
Ohio
12 studies recruiting.
Multiple sclerosis medication studies recruiting now
As of November 17, 2026, 53 multiple sclerosis medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a medication, as each study is coded in the registry. This is what they have in common.
What they test
- medications53
- other approaches7
- biologics such as vaccines or antibodies6
- devices2
- procedures2
A study can test more than one.
Main purpose
- treating a condition41
- diagnosis8
- basic science2
- other purposes1
Phase
- Early Phase 13
- Phase 111
- Phase 1/27
- Phase 213
- Phase 2/31
- Phase 39
- Phase 47
- No phase2
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other26
- industry23
- government4
Who they enroll
- adults (18 to 64)51
- older adults (65 and over)35
- children (under 18)2
11 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 53 studies.
Recently updated multiple sclerosis medication studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
- Phase 1
- Ages 18 to 75
- All sexes
- Sponsor
- Kite, A Gilead Company
- Recruiting in
- New York, NY · Newport Beach, CA · Palo Alto, CA · and 2 more U.S. locations
- Registry record
- NCT07304154 · updated
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Baltimore, MD · Bethesda, MD · Boston, MA · and 28 more U.S. locations
- Registry record
- NCT03816345 · updated
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- Albuquerque, NM · Boca Raton, FL · Bradenton, FL · and 22 more U.S. locations
- Registry record
- NCT07299019 · updated
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- Bradenton, FL · Columbus, OH · Cordova, TN · and 15 more U.S. locations
- Registry record
- NCT07067463 · updated
A Study of AZD0120 in Autoimmune Diseases
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Ann Arbor, MI · Chapel Hill, NC · New York, NY
- Registry record
- NCT07295847 · updated
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Phase 2
- Ages 18 to 60
- All sexes
- Sponsor
- Johns Hopkins University
- Recruiting in
- Baltimore, MD · Kansas City, KS · New York, NY
- Registry record
- NCT07497399 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in the United States on ClinicalTrials.gov.
What multiple sclerosis studies look at
What you would be asked to do depends on the study you look into. Each multiple sclerosis study is set up around one particular question of its own, and the tasks for participants follow from that question. Taken together, MS studies examine investigational medications and rehabilitation approaches for relapsing and progressive forms of MS.
Keep one thing in mind as you read. A medication or approach under study is investigational. Researchers have not finished learning what its risks are or how well it works, and finding that out is the purpose of the study.
Who may be able to take part
At a screening visit, the study team checks whether you meet a study's requirements, so sorting out eligibility is not a job you have to take on yourself. Read how eligibility and screening work.
Those requirements differ from one MS medication trial to the next. A study might ask how old you are, look at your medical background, review which medicines you currently use, and consider how MS affects you. Some also enroll people who do not have the condition.
What taking part usually involves
A first conversation
First you talk with a coordinator. You hear a broad outline of the study and can ask whatever is on your mind, and nothing further happens until that conversation is done.
Informed consent
You will receive the complete details of the MS medication trial in writing from the study team, and that covers the risks that are known. Then you choose. Agreeing or declining is entirely up to you.
Screening
You then answer health questions and have tests, which tell the team if this study fits you. Screening does not always lead to enrollment.
Study visits
If you decide to join the MS medication trial, you come in for appointments planned ahead by the study team, who use them to follow your health. Leaving stays open to you. You may withdraw at any point.
Questions about multiple sclerosis medication studies
Do I need a diagnosis to join a study about multiple sclerosis?
The study team will tell you what applies to you, because this varies by study. Some require a confirmed diagnosis. Others assess you during screening.
Would I have to change the care I receive now?
Please do not change any of your care on your own. The study doctor goes over this with you, since some studies let current care continue and others do not. Before you decide, you can also talk it through with your own doctor.
Is there a cost to take part?
The study medication, the tests a study requires, and the visits themselves generally come at no cost to you as a participant. Learn how study costs are handled.
Ask about multiple sclerosis medication studies
After you send us a few details, expect to hear from a coordinator. Sending them does not bind you to anything.
Independent information
- Multiple Sclerosis (MS) — National Institute of Neurological Disorders and Stroke (NIH)
- Clinical Trials — MedlinePlus (National Library of Medicine)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)